Experience with the use of daptomycin in patients with infective endocarditis oncohematological and cardiosurgical profile
- Authors: Khubulava V.G.1, Turin VP1, Koltsov AV2, Fisun AY.1, Fisun AY.1
-
Affiliations:
- Военно-медицинская академия им. С.М. Кирова
- Национальный медико-хирургический центр им. Н.И. Пирогова
- Issue: Vol 20, No 4 (2018)
- Pages: 18-21
- Section: Articles
- URL: https://journals.rcsi.science/1682-7392/article/view/12237
- DOI: https://doi.org/10.17816/brmma12237
- ID: 12237
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
VV GG Khubulava
Военно-медицинская академия им. С.М. Кирова
Email: vmeda-nio@mil.ru
Санкт-Петербург
V P Turin
Военно-медицинская академия им. С.М. Кирова
Email: vmeda-nio@mil.ru
Санкт-Петербург
A V Koltsov
Национальный медико-хирургический центр им. Н.И. ПироговаМосква
A Ya Fisun
Военно-медицинская академия им. С.М. Кирова
Email: vmeda-nio@mil.ru
Санкт-Петербург
A Ya Fisun
Военно-медицинская академия им. С.М. Кирова
Email: vmeda-nio@mil.ru
Санкт-Петербург
References
- Дехнич, А.В. Даптомицин: обзор фармакологических, клини- ческих и микробиологических параметров / А.В. Дехнич, А.И. Данилов // Клин. микробиол. и антимикробная хими- отерапия. - 2010. - № 12 (4). - С. 295-313.
- Baddour, L.M. Clinical practice. Infections of cardiovascular implantable electronic devices / L.M. Baddour, Y.M. Cha, W.R. Wilson // N. Engl. J. Med. - 2012. - № 367. - P. 842-849.
- Canton, R. A potential role for daptomycin in enterococcal infections: what is the evidence? / R. Canton, R. Chaves, A. Johnson // J. Antimicrob. Chemother. - 2010. - № 65. - P. 1126-1136.
- Fowler, V.G. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus / V.G. Fowler [et al.] // N. Engl. J. Med. - 2006. - № 355. - P. 653-665.
- Gaca, J.G. Outcomes for endocarditis surgery in North America: a simplified risk scoring system / J.G. Gaca [et al.] // J. Thorac. Cardiovasc. Surg. - 2011. - № 141. - P. 98-106.
- Guleri, A. Effectiveness and safety of daptomycin in patients with infective endocarditis undergoing heart valve replacement: a subgroup analysis from real-world data / A. Guleri, R. Utili, P. Dohmen, K. Hamed // Ther. Adv. Infect. Dis. - 2017. - № 4 (2).- P. 41-47.
- Habib, G. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC) / G. Habib [et al.] // Eur. Heart. J.- 2015. - № 364 (4). - P. 3075-3128.
- Kang, D.H. Early surgery versus conventional treatment for infective endocarditis / D.H. Kang [et al.] // N. Engl. J. Med. - 2012. - № 366. - P. 2466-2473.
- Nadrah, K. Antibiotic combinations with daptomycin for treatment of Staphylococcus aureus infections / K. Nadrah, F. Strle // Chemotherapy Research and Practice. - 2011. - № 2011. - Р.10.
- Popov, A.F. Daptomycin as a possible new treatment option for surgical management of Methiillin-resistant Staphylococcus aureus sternal wound infection after cardiac surgery / A.F. Popov, J.D. Schmitto, T. Tirilomis // J. Cardiothorac Surg. - 2010. - № 5 (1). - Р. 57.
- Rabkin, D.G. Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users / D.G. Rabkin [et al.] // Ann. Thorac. Surg. - 2012. - № 93. - P. 51-57.
- Safdar, N. In vivo pharmacodynamic activity of daptomycin / N. Safdar, D. Andes, W.A. Craig // Antimicrob Agents Chemother. - 2004. - № 48. - P. 63-68.
- Sohail, M.R. Infective endocarditis complicating permanent pacemaker and implantable cardioverterdefibrillator infection / M.R. Sohail [et al.] // Mayo Clin. Proc. - 2008. - № 83. - P. 46-53.
- Thuny, F. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multicentre study / F. Thuny [et al.] // Eur. Heart J. - 2007. - № 28. - P.1155-1161.